Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Colorectal Cancer
9 articles
Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Unmasking the Risk Factors: New Insights into Immune-Mediated Hepatotoxicity in Cancer Immunotherapy
Meta-analysis reveals key risk factors for liver toxicity in cancer patients receiving immunotherapy
Genetic Variants Linked to Higher Mortality Risk in Cancer Chemotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.
SOLAR Trial: Revolutionizing Rectal Cancer Treatment with Short-Course Radiotherapy
New trial compares short-course radiotherapy plus chemotherapy to standard chemoradiotherapy for rectal cancer
Breakthrough Combo Therapy Shows Promise for Colorectal Cancer
New drug combination significantly improves outcomes for patients with advanced colorectal cancer
Fucoidan Boosts Quality of Life for Rectal Cancer Patients During Treatment
Study finds fucoidan supplement improves physical well-being in rectal cancer patients receiving chemoradiation
Natural Compounds Show Promise in Colorectal Cancer Prevention
Study explores effects of curcumin and anthocyanins on biomarkers in patients with colorectal adenomas
Cetuximab Maintenance Therapy Shows Promise for Colorectal Cancer
Study finds cetuximab maintenance may benefit some colorectal cancer patients after initial treatment
Zinc Supplementation Reduces Severe Hand-Foot Skin Reaction in Cancer Patients
Study shows zinc supplements decrease severe hand-foot skin reactions from regorafenib cancer drug